“We are delighted to see more regulatory authorities using the voluntary DCP process,” explained Dr Rainer Kolkmann, Head of Product Development at Diapharm: “This common procedure is still rarely used in the case of traditional herbal medical products. It can significantly reduce the bureaucratic complexity, both for the authorities and pharmaceutical companies.” The common authorisation process is also a testament to the fact that the EU directive on traditional herbal medicinal products is now accepted throughout Europe. Diapharm has helped manage over 500 product authorisations and approvals for phytopharmaceuticals in 23 European countries.
(approx. 1.400 characters)